ArticleFrontiers in oncology2022

Survival, response rates, and post-transplant outcomes in patients with Acute Myeloid Leukemia aged 60-75 treated with high intensity chemotherapy vs. lower intensity targeted therapy.

Kieran Sahasrabudhe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.